Plague vaccines: current developments and future perspectives.
about
Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensPlague Vaccine Development: Current Research and Future TrendsDeletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague.HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.Russian vaccines against especially dangerous bacterial pathogens.YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected].High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.Yersinia pestis Caf1 Protein: Effect of Sequence Polymorphism on Intrinsic Disorder Propensity, Serological Cross-Reactivity and Cross-Protectivity of IsoformsRecombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection.A Recombinant Trivalent Fusion Protein F1-LcrV-HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestisResistance of Mice of the 129 Background to Yersinia pestis Maps to Multiple Loci on Chromosome 1.Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague.A study on the efficacy of the recombinant Yersinia adhesin A vaccine against yersiniosis in the early phase.Assessment of Live Plague Vaccine Candidates.Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis.A safety and immunogenicity study of a novel subunit plague vaccine in cynomolgus macaques.Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine.Targeting of the F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague
P2860
Q27011190-17653E57-3301-4276-96B1-BBDCEEB3411BQ28066875-D54021F7-4664-475B-9CAD-445E0F95C9E5Q33603015-6EC01A24-4595-4E9E-BAA6-25FA8118CB63Q33819353-A4EF63E9-9886-4C9A-8F57-A3B00D480D37Q34633478-F0A725E8-50F1-455B-8717-4F7C632A68A5Q35050833-383C290A-850B-4718-B6BF-23F49054B29AQ35073117-754AA33D-365D-4444-AFFA-6E80064DFAC5Q35439470-A4E05C18-D318-4C9C-A808-8F98D33E45A0Q36126137-867EF3D0-9590-4488-A54B-4403CDEC0BE7Q36373952-B436BA90-A06C-476A-AE7B-76B7BFDB95AFQ37064828-E8574398-9E8C-474B-A432-454E0B598EBBQ37287202-7E1C3B61-8E90-456E-9E85-E7E0CF8C832BQ37588454-1ED3CFBB-A6AE-482E-AF8B-33C05A8F6807Q40287170-3AB89B68-57B2-45FC-B076-02223529F7BAQ40715711-8CA5B7CC-6E5B-4A23-B581-602A2699D630Q46463260-B5C63AB1-1449-4CD7-AA96-92FBC89BCC74Q48309869-09EB4920-8B5F-4820-87A3-33ACA90C1F2BQ55361721-6D6CF7E2-1BAB-4744-9999-431AE561977EQ55456478-6ED37E22-6C31-4A5E-9AB3-C77F6E42A8F6Q58121119-72755183-EA8F-47BE-B1D8-3312E2362B72
P2860
Plague vaccines: current developments and future perspectives.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plague vaccines: current developments and future perspectives.
@en
type
label
Plague vaccines: current developments and future perspectives.
@en
prefLabel
Plague vaccines: current developments and future perspectives.
@en
P2860
P356
P1476
Plague vaccines: current developments and future perspectives.
@en
P2093
Valentina A Feodorova
Vladimir L Motin
P2860
P2888
P356
10.1038/EMI.2012.34
P577
2012-11-07T00:00:00Z
P5875
P6179
1027481973